Press release
Next Generation Cancer Diagnostic Devices Market: Growth, Trends, & Innovations 2025 | GE HealthCare, Illumina, Inc., Novartis AG.
Next Generation Cancer Diagnostic Devices Market
Will the Next Generation Cancer Diagnostic Devices market emerge as the sector's next great thing? To discover the answer, look at the Next Generation Cancer Diagnostic Devices market analysis and projections. In-depth insight of the opportunities, difficulties, and trends now impacting the industrial landscape is provided by this market research study, empowering industry participants to make informed decisions in a changing environment. Take advantage of the opportunity in the Next Generation Cancer Diagnostic Devices market! (2031)
Download Free Sample PDF: https://www.datamintelligence.com/download-sample/next-generation-cancer-diagnostic-devices-market
The Global Next Generation Cancer Diagnostic Devices Market reached US$ 18.12 billion in 2024 and is expected to reach US$ 61.14 billion by 2033, growing at a CAGR of 15.2% during the forecast period 2025-2033.
The Next-generation cancer diagnostic devices market focuses on advanced technologies for early, precise, and non-invasive cancer detection. These devices utilize innovations like liquid biopsies, next-generation sequencing (NGS), biomarkers, and AI-powered diagnostic tools to improve accuracy and speed. Driven by rising cancer prevalence, personalized medicine, and advancements in genomics, this market plays a critical role in transforming cancer diagnosis and patient care.
Key Players:
Profiles of some of the major players in the global Next Generation Cancer Diagnostic Devices market, which include GE HealthCare, Illumina, Inc., Novartis AG, F. Hoffmann-La Roche Ltd, Koninklijke Philips N.V, QIAGEN, Agilent Technologies, Inc., Abbott, Thermo Fisher Scientific Inc., BD among others.
Industry Development:
In May 2024, Foundation Medicine Inc. introduced Foundation One RNA, a tissue-based RNA sequencing test designed to detect cancer-related fusions across 318 genes. This advanced diagnostic tool reports fusions in all solid tumors and is particularly valuable for identifying fusions in cancers such as non-small cell lung cancer (NSCLC), pancreatic cancer, cholangiocarcinoma, sarcoma, thyroid cancer, and bladder cancer. The launch underscores Foundation Medicine's commitment to precision oncology by providing critical insights to guide targeted treatment strategies.
The purpose of the report is to offer a comprehensive analysis of the market, along with insightful conclusions, statistical data, historical information, market data that has been confirmed by the industry, and predictions based on a sound methodology. By identifying and examining market segments and forecasting global market size, the study also contributes to understanding the dynamics and structure of the global Next Generation Cancer Diagnostic Devices market.
Get this Premium Report: https://www.datamintelligence.com/buy-now-page?report=next-generation-cancer-diagnostic-devices-market
Market Segments:
The report covers the segmentation of the market into different segments based on various classifications such as applications, end users, product types, and others. The segmentation is divided into two sections, one for development and the other for different roles, needs, and behaviors.
By Technology: Next-generation Sequencing, qPCR & Multiplexing, Lab-on-a-chip (LOAC), Protein Microarrays, DNA Microarrays.
By Cancer Type: Lung Cancer, Breast Cancer, Colorectal Cancer, Cervical Cancer, Others.
By Application: Biomarker Development, CTC Analysis, Proteomic Analysis, Epigenetic Analysis, Genetic Analysis.
By End User: Hospitals, Cancer Research Institutes, Diagnostic Centers.
Regional Break out:
The global Next Generation Cancer Diagnostic Devices Market report focuses on six major regions: North America, South America, Europe, Asia Pacific, the Middle East, and Africa.
☞ North America - US, Canada, Mexico
☞ Europe- Germany, Russia, UK, France, Italy, Rest of Europe
☞ Asia Pacific- China, India, Japan, Australia, Rest of Asia Pacific
☞ South America- Brazil, Argentina, Colombia, Rest of South America
☞ Middle East and Africa- Saudi Arabia, UAE, Oman, Bahrain, Qatar, Kuwait, Israel
Points Covered:
⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Next Generation Cancer Diagnostic Devices market segments, study objectives, and years considered.
⏩ Market Landscape: The competition in the Global Next Generation Cancer Diagnostic Devices Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.
⏩ Companies Profiles: The global Next Generation Cancer Diagnostic Devices market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.
⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.
⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Next Generation Cancer Diagnostic Devices Market.
⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.
⏩ Research Findings: This section of the report showcases the findings and analysis of the report.
⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.
Speak to our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/next-generation-cancer-diagnostic-devices-market
FAQ's
Q.1. What are the primary drivers of the Next Generation Cancer Diagnostic Devices Industry?
Q.2. What are the main factors propelling and impeding the growth of the Next Generation Cancer Diagnostic Devices market?
Q.3. What are the general structure, risks, and opportunities of the market?
Q.4. How do the prices, revenue, and sales of the leading Next Generation Cancer Diagnostic Devices market firms compare?
Q.5. What are the main segments of the market and how is it divided up?
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Next Generation Cancer Diagnostic Devices Market: Growth, Trends, & Innovations 2025 | GE HealthCare, Illumina, Inc., Novartis AG. here
News-ID: 3812342 • Views: …
More Releases from DataM Intelligence 4Market Research
United States Agricultural Micronutrients Market Set for Robust Growth as Farmer …
Market Size and Growth:
The Global Agricultural Micronutrients Market size reached USD 9,706 million in 2022 and is projected to witness lucrative growth by reaching up to USD 19,197 million by 2031. The market is expected to exhibit a CAGR of 9% during the forecast period (2024-2031).
The Agricultural Micronutrients Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth…
United States Telemedicine Market Set for Explosive Growth as Virtual Healthcare …
Market Size and Growth:
The Global Telemedicine Market size reached US$129.70 billion in 2024 and is expected to reach US$488.89 billion by 2033, growing at a CAGR of 16.8% during the forecast period 2025-2033
The Telemedicine Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market participants to capitalize on these…
United States Clinical Trial Management System Market Set for Robust Growth with …
Market Size and Growth:
The Global Clinical Trial Management System Market size reached USD 1.5 billion in 2022 and is projected to witness lucrative growth by reaching up to USD 4.2 billion by 2031. The global clinical trial management system market is expected to exhibit a CAGR of 14.6% during the forecast period (2024-2031).
The Clinical Trial Management System Market report by DataM Intelligence provides insights into the latest trends and developments…
United States Healthcare Chatbots Market Set for Robust Growth as AI-Driven Pati …
Market Size and Growth:
The Healthcare Chatbots Market size reached US$ 823.96 Million in 2024 and is expected to reach US$ 5,692.97 Million by 2033, growing at a CAGR of 22.9% during the forecast period 2025-2033.
The Healthcare Chatbots Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market participants to…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
